Heroin-assisted treatment in the Netherlands: History, findings, and international context (Q45340080)

13 December 2017

title

Heroin-assisted treatment in the Netherlands: History, findings, and international context (English)

1 reference

13 December 2017

0 references

2

Wim van den Brink

1 reference

13 December 2017

9

Jos H Beijnen

1 reference

13 December 2017

Peter Blanken

1

1 reference

13 December 2017

Vincent M Hendriks

3

1 reference

13 December 2017

Ineke A Huijsman

4

1 reference

13 December 2017

Marjolein G Klous

5

1 reference

13 December 2017

Elisabeth J Rook

6

1 reference

13 December 2017

Jennifer S Wakelin

7

1 reference

13 December 2017

Cas Barendrecht

8

1 reference

13 December 2017

Jan M van Ree

10

1 reference

13 December 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

European Neuropsychopharmacology

13 December 2017

published in

1 reference

13 December 2017

volume

20 Suppl 2

1 reference

13 December 2017

page(s)

S105-58

1 reference

Reactivity to laboratory stress provocation predicts relapse to cocaine

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Analysis of cost data in randomized trials: an application of the non-parametric bootstrap

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

EuroQol: the current state of play

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Chasing the dragon, related to the impaired lung function among heroin users

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Influence of treatment with inhalable heroin on pulmonary function

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Psychosocial Treatments for Cocaine Dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Variations in methadone treatment practices. Results from a national study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Employment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Temporal and geographic variations in the characteristics of heroin seized in Spain and their relation with the route of administration. Spanish Group for the Study of the Purity of Seized Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

A meta-analytic review of psychosocial interventions for substance use disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

The Swiss heroin trials: testing alternative approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Heroin maintenance treatment for chronic heroin-dependent individuals: a Cochrane systematic review of effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Heroin-assisted treatment as a response to the public health problem of opiate dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Illicit opioid use and treatment for opioid dependence: challenges for Canada and beyond.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Pilot study to determine the effectiveness of diamorphine gel to control pressure ulcer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

[Economic evaluation of the Swiss project on medically prescribed heroin substitution treatment]

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

A prospective cohort study on orally administered heroin substitution for severely addicted opioid users

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Heroin-assisted treatment for opioid dependence: Randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Is heroin-assisted treatment effective for patients with no previous maintenance treatment? Results from a German randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Patient-controlled intranasal diamorphine for postoperative pain: an acceptability study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Comparison of intrathecal and epidural diamorphine for elective caesarean section using a combined spinal-epidural technique.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Patterns of heroin use: what do we know?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Evaluation of heroin maintenance in controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Purity Profiles for Heroin, Morphine, and Morphine Hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Heroin self-administration by means of 'chasing the dragon': pharmacodynamics and bioavailability of inhaled heroin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Contact allergy and respiratory/mucosal complaints from heroin (diacetylmorphine).

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Analytical studies on illicit heroin. V. Efficacy of volatilization during heroin smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

The pharmacokinetics of heroin in patients with chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Evidence from opiate binding studies that heroin acts through its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Prediction of long-term outcome for heroin addicts admitted to a methadone maintenance program

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Impurities, adulterants and diluents of illicit heroin in Denmark (Jutland and Funen)

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Intranasal diamorphine as an alternative to intramuscular morphine: pharmacokinetic and pharmacodynamic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Multicentre randomised controlled trial of nasal diamorphine for analgesia in children and teenagers with clinical fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Pharmaceutical heroin for inhalation: thermal analysis and recovery experiments after volatilisation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Analysis of diacetylmorphine, caffeine, and degradation products after volatilization of pharmaceutical heroin for inhalation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Development and manufacture of diacetylmorphine/caffeine sachets for inhalation via 'chasing the dragon' by heroin addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Process characterisation, optimisation and validation of production of diacetylmorphine/caffeine sachets: a design of experiments approach

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Deuterodiacetylmorphine as a marker for use of illicit heroin by addicts in a heroin-assisted treatment program

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Addiction is a brain disease, and it matters

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Pre- and in-treatment predictors of retention in methadone treatment using survival analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Smoking cessation and weight loss after chronic deep brain stimulation of the nucleus accumbens: therapeutic and research implications: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Controlled trial of prescribed heroin in the treatment of opioid addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Attentional bias predicts heroin relapse following treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Prescribing drug of choice to illicit heroin users: the experience of a U.K. community drug team

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Intravesical diamorphine for bladder spasm

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Survey of doctors prescribing diamorphine (heroin) to opiate-dependent drug users in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Patients receiving a prescription for diamorphine (heroin) in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Motivational interviewing: research, practice, and puzzles

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Toward a theory of motivational interviewing

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

The rational use of intrathecal and extradural opioids

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Drugs and syringe drivers: a survey of adult specialist palliative care practice in the United Kingdom and Eire

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Blood-Brain Barrier: Penetration of Morphine, Codeine, Heroin, and Methadone after Carotid Injection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Diacetylmorphine versus methadone for the treatment of opioid addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: rationale and design of the NAOMI study.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Efficacy of prescribed injectable diacetylmorphine in the Andalusian trial: Bayesian analysis of responders and non-responders according to a multi domain outcome index.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Oral heroin in opioid-dependent patients: pharmacokinetic comparison of immediate and extended release tablets

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Contingency management treatments: Reinforcing abstinence versus adherence with goal-related activities

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Stability of Brompton mixtures: determination of heroin (diacetylmorphine) and cocaine in presence of their hydrolysis products.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Quality of heroin and heroin-related deaths from 1987 to 1995 in Vienna, Austria.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Abstinence-contingent reinforcement and engagement in non-drug-related activities among illicit drug abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Population pharmacokinetics of heroin and its major metabolites.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Mast cell mediator tryptase levels after inhalation or intravenous administration of high doses pharmaceutically prepared heroin.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Screening for illicit heroin use in patients in a heroin-assisted treatment program.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Human erythrocyte but not brain acetylcholinesterase hydrolyses heroin to morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Paediatric regional anaesthesia, a survey of practice in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

NAOMI--her time has come. North American Opiate Medication Initiative

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

The neurosurgical treatment of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

The discovery of heroin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Illusory predictors: Generalizability of findings in cocaine treatment retention research

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Heroin in the United Kingdom: different forms, different origins, and the relationship to different routes of administration

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Political challenges in randomized controlled trials of heroin-assisted treatment for severe heroin addiction: a Spanish experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Evidenced-based treatment of opioid-dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Heroin assisted treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Patterns of acquisitive crime during methadone maintenance treatment among patients eligible for heroin assisted treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Long-term effects of heroin-assisted treatment in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

A comparison of patient-controlled analgesia administered by the intravenous or intranasal route during the early postoperative period

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Sublingual absorption of selected opioid analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Intranasal diamorphine for paediatric analgesia: assessment of safety and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Leucoencephalopathy after inhaling "heroin" pyrolysate

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Isolation and identification of morphine 3- and 6-glucuronides, morphine 3,6-diglucuronide, morphine 3-ethereal sulfate, normorphine, and normorphine 6-glucuronide as morphine metabolites in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Identification of Diacetylmorphine Metabolites in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

A New Design for Randomized Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Randomized consent designs for clinical trials: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

Patterns of heroin use

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2810%2970001-8

7 January 2021

10.1016/S0924-977X(10)70001-8

Identifiers

DOI

1 reference

13 December 2017

1 reference